文献速递外周动脉疾病

不可血运重建慢性肢体威胁性缺血患者的长期生存与保肢

Long Term Survival and Limb Salvage in Patients With Non-Revascularisable Chronic Limb Threatening Ischaemia.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2021-06-02

本研究基于JUVENTAS随机对照试验的前瞻性数据,回顾性分析150例不可血运重建(NR)慢性肢体威胁性缺血(CLTI)患者的长期结局。纳入后5年无截肢生存率为43%,全因死亡与截肢各占35%和33%,截肢主要发生在第一年;截肢患者中33%后续死亡,中位间隔291天。

要点

  • NR-CLTI患者5年无截肢生存率43%,死亡与截肢率相近。
  • 截肢主要发生在纳入后第一年,尤其伴组织缺损者。
  • 截肢后患者死亡风险高,中位间隔约291天。

核心结论

  • 不可血运重建CLTI患者5年时约半数存活且保肢,但整体预后仍差。
  • 在优化内科治疗下,其无截肢生存可能与可血运重建CLTI患者相当。
  • 伴缺血性组织缺损的NR-CLTI患者一年内大截肢率非常高。

研究设计与样本

  • 回顾性分析前瞻性收集的JUVENTAS随机对照试验数据。
  • 纳入150例纳入时无血运重建选择的CLTI患者。
  • 主要结局为纳入后5年无截肢生存(生存与保肢的复合终点)。

主要发现

  • 150例NR-CLTI患者纳入后5年无截肢生存率为43%。
  • 全因死亡率为35%,截肢率为33%。
  • 截肢主要发生在第一年。
  • 截肢患者中33%在研究期间死亡,中位间隔291天。

临床怎么用

  • 对NR-CLTI患者应强调优化内科治疗以改善无截肢生存。
  • 需重点关注第一年内的截肢风险,尤其伴组织缺损者。
  • 截肢后应加强随访管理,警惕高死亡风险。

局限性

  • 为回顾性分析,数据源自再生细胞治疗试验人群。
  • 原文未报告具体统计不确定性及混杂因素调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to provide long term survival and limb salvage rates for patients with non-revascularisable (NR) chronic limb threatening ischaemia (CLTI). METHODS: This was a retrospective review of prospectively collected data, derived from a randomised controlled trial (JUVENTAS) investigating the use of a regenerative cell therapy. Survival and limb salvage of the index limb in CLTI patients without viable options for revascularisation at inclusion were analysed retrospectively. The primary outcome was amputation free survival, a composite of survival and limb salvage, at five years after inclusion in the original trial. RESULTS: In 150 patients with NR-CLTI, amputation free survival was 43% five years after inclusion. This outcome was driven by an equal rate of all cause mortality (35%) and amputation (33%). Amputation occurred predominantly in the first year. Furthermore, 33% of those with amputation subsequently died within the investigated period, with a median interval of 291 days. CONCLUSION: Five years after the initial need for revascularisation, about half of the CLTI patients who were deemed non-revascularisable survived with salvage of the index limb. Although the prospects for these high risk patients are still poor, under optimal medical care, amputation free survival seems comparable with that of revascularisable CLTI patients, while the major amputation rate within one year, especially among NR-CLTI patients with ischaemic tissue loss, is very high.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Verwer MC, Wijnand JGJ, Teraa M, et al. Long Term Survival and Limb Salvage in Patients With Non-Revascularisable Chronic Limb Threatening Ischaemia. Eur J Vasc Endovasc Surg. 2021. PMID: 34090781. doi:10.1016/j.ejvs.2021.04.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。